Allergan Exec Bonus Suit Should Be Axed, Judge Says
A Delaware magistrate judge urged the court on Thursday toss a shareholder derivative suit claiming Allergan Inc.'s directors gave investors misleading information about a proposed executive bonus plan, saying the pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article